Find Hydroxydopamine Hydrobromide manufacturers, exporters & distributors on PharmaCompass

Hydroxydopamine Hydrobromide

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

1 API Suppliers, 1 USDMF

1 API Suppliers
1 USDMF

DIGITAL CONTENT

1 NEWS #PharmaBuzz

media
1 NEWS #PharmaBuzz

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 636-00-0, Oxidopamine hydrobromide, Oxidopamine (hydrobromide), 6-hydroxydopamine hbr, 6-ohda, 2,4,5-trihydroxyphenethylamine hydrobromide

Molecular Formula

C₈H₁₂BrNO₃

Molecular Weight

250.09 g/mol

InChI Key

MLACDGUOKDOLGC-UHFFFAOYSA-N

FDA UNII

TWC1D4W0WB

A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.

1 2D Structure

Hydroxydopamine Hydrobromide

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

5-(2-aminoethyl)benzene-1,2,4-triol;hydrobromide

2.1.2 InChI

InChI=1S/C8H11NO3.BrH/c9-2-1-5-3-7(11)8(12)4-6(5)10;/h3-4,10-12H,1-2,9H2;1H

2.1.3 InChI Key

MLACDGUOKDOLGC-UHFFFAOYSA-N

2.1.4 Canonical SMILES

C1=C(C(=CC(=C1O)O)O)CCN.Br

2.2 Other Identifiers

2.2.1 UNII

TWC1D4W0WB

2.3 Synonyms

2.3.1 MeSH Synonyms

1. 6 Hydroxydopamine

2. 6-hydroxydopamine

3. 6-ohda

4. Hydrobromide, Oxidopamine

5. Hydrochloride, Oxidopamine

6. Oxidopamine

7. Oxidopamine Hydrobromide

8. Oxidopamine Hydrochloride

2.3.2 Depositor-Supplied Synonyms

1. 636-00-0

2. Oxidopamine Hydrobromide

3. Oxidopamine (hydrobromide)

4. 6-hydroxydopamine Hbr

5. 6-ohda

6. 2,4,5-trihydroxyphenethylamine Hydrobromide

7. 5-(2-aminoethyl)benzene-1,2,4-triol Hydrobromide

8. 6-ohda Hbr

9. Mfcd00012894

10. Twc1d4w0wb

11. 2-(2,4,5-trihydroxyphenyl)ethylamine Hydrobromide

12. 1,2,4-benzenetriol, 5-(2-aminoethyl)-, Hydrobromide

13. 6-hydroxydopamine Hydrobromide;6-ohda Hydrobromide

14. Nsc-238469

15. 636-00-0 (hbr)

16. 6-hydroxydopamine Hydrogen Bromide

17. Mls002207128

18. 2,5-dihydroxytyramine Hydrobromide

19. Smr001306725

20. Einecs 211-247-0

21. Unii-twc1d4w0wb

22. Nsc 238469

23. 5-(2-aminoethyl)-4-hydroxypyrocatechol Hydrobromide

24. 5-(2-aminoethyl)benzene-1,2,4-triol;hydrobromide

25. 6-ohda Hydrobromide

26. 6-hydroxydopamine.hydrobromide

27. Schembl738049

28. 4-chlorobenzenecarbaldehydeoxime

29. Chembl1718398

30. Hy-b1081a

31. Dtxsid30212972

32. Wln: Z2r Bq Dq Eq &eh

33. Bcp25700

34. Ex-a4152

35. 6-hydroxydopamine Hydrobromide, 95%

36. Nsc238469

37. S5324

38. Akos015916618

39. Ccg-266959

40. Cs-5966

41. As-40064

42. Sy102034

43. Db-054509

44. B7099

45. Ft-0632700

46. M01851

47. 6-ohda Hydrobromide6-hydroxydopamine Hydrobromide

48. A935047

49. 1,4-benzenetriol, 5-(2-aminoethyl)-, Hydrobromide

50. 5-(2-aminoethyl)-1,2,4-benzenetriol Hydrobromide

51. 6-hydroxydopamine Hydrobromide, >=90% (hplc), Solid

52. Q27290460

53. 1,2,4-benzenetriol, 5-(2-aminoethyl)-, Hydrobromide (1:1)

54. 6-ohda Hbr; 6 Ohda Hbr;oxidopamine Hydrobromide; 6-hydroxydopamine Hbr

55. 6-hydroxydopamine Hydrobromide, Contains Ascorbic Acid As Stabilizer, >=98% (hplc)

2.4 Create Date

2005-07-19

3 Chemical and Physical Properties

Molecular Formula	C₈H₁₂BrNO₃
Molecular Weight	250.09 g/mol
Hydrogen Bond Donor Count	5
Hydrogen Bond Acceptor Count	4
Rotatable Bond Count	2
Exact Mass	249.00006 g/mol
Monoisotopic Mass	249.00006 g/mol
Topological Polar Surface Area	86.7 Å²
Heavy Atom Count	13
Formal Charge	0
Complexity	142
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	2

4 Pharmacology and Biochemistry

4.1 MeSH Pharmacological Classification

Sympatholytics

Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here. (See all compounds classified as Sympatholytics.)

Adrenergic Agents

Drugs that act on adrenergic receptors or affect the life cycle of adrenergic transmitters. Included here are adrenergic agonists and antagonists and agents that affect the synthesis, storage, uptake, metabolism, or release of adrenergic transmitters. (See all compounds classified as Adrenergic Agents.)

API SUPPLIERS